Does UPADACITINIB Cause C-reactive protein increased? 197 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 197 reports of C-reactive protein increased have been filed in association with UPADACITINIB (Rinvoq). This represents 0.3% of all adverse event reports for UPADACITINIB.
197
Reports of C-reactive protein increased with UPADACITINIB
0.3%
of all UPADACITINIB reports
17
Deaths
112
Hospitalizations
How Dangerous Is C-reactive protein increased From UPADACITINIB?
Of the 197 reports, 17 (8.6%) resulted in death, 112 (56.9%) required hospitalization, and 14 (7.1%) were considered life-threatening.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 197 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which UPADACITINIB Alternatives Have Lower C-reactive protein increased Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL